You are here: Industry Insights > IPO

News List

Mereo BioPharma's Rationale for Halting IPO Draws Skepticism biospace
April 28, 2018
UK-based Mereo BioPharma pulled its planned initial public offering (IPO) on the Nasdaq Global Market, saying market conditions were not in the best interests of its shareholders.
Abpro Therapeutics on deck for IPO biospectrumasia
April 16, 2018
Co-lead candidates are ABP-100 and ABP-201, both tetravalent antibodies, meaning they bind to two different targets with two distinct binding sites per target.
RMB 5.741 Billion to Raise! The Second Unicorn This Year—CRO Dominant Wuxi AppTec to be Listed on Shanghai Stock Exchange Caicai
April 11, 2018
WuXi AppTec Co., Ltd. was in the IPO list on March 27, with the intention to be listed on Shanghai Stock Exchange and raise fund of about RMB 5.741 billion. If everything goes well, it will be successfully listed next week, being the second unicorn listed
Inspire files for $86.25M IPO biospectrumasia
April 10, 2018
The company plans to list on the NYSE under the symbol INSP.
Unity Biotechnology Looking to Infuse New Life through $85M IPO biospace
April 08, 2018
A company focused on aging-related ailments is looking to infuse new life into its coffers through an initial public offering.
Homology Medicines Snags $144 Million IPO biospace
March 29, 2018
Two months after securing a new facility in Bedford, Mass., Homology Medicineshas raised $144 million in an initial public offering of stock.
Hua Medicine picks Hong Kong, S.A.R., China for IPO biospectrumasia
March 12, 2018
The offering could raise as much as $300 million.
Chinese Tycoon Eyes $500M IPO of Luye Life Sciences' Clinic Arm biospace
January 25, 2018
Luye Life Sciences Group, run by acquisitive Chinese entrepreneur Liu Dianbo, is considering a Singapore initial public offering of its health-care services arm that could raise as much as $500 million, people with knowledge of the matter said.
The 2017 Biotech IPO Winners and Losers biospace
December 26, 2017
Although it was an average year for mergers and acquisitions in the biopharma industry, it was a stronger year for initial public offerings (IPO).
Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials iercebiotech
December 11, 2017
Denali Therapeutics has raised $250 million. The IPO, the biggest biotech listing of the year, sets Denali up to push drugs against Alzheimer’s and Parkinson’s diseases through early clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 Next page